Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Zeo ScientifiX, Inc.
- Market Cap
- Unavailable
- Price
- $1.57
- % Change (Daily % change from the live per-ticker quote feed.)
- +10.63%
- Volume
- 482
About
Zeo ScientifiX, Inc. is a clinical-stage biopharmaceutical company specializing in developing biological therapeutics aimed at treating degenerative diseases and fostering regenerative medicine. Its flagship investigational product, Zofin, is an acellular biologic therapy sourced from perinatal materials. This candidate is currently in Phase I/II clinical trials, evaluating its efficacy for COVID-19, chronic obstructive pulmonary disease (COPD), and knee osteoarthritis. The company's portfolio also includes Patient Pure X, an autologous, blood-derived biologic technology designed to enhance the body's natural capacity to reduce cellular inflammation and promote tissue healing. Furthermore, Zeo ScientifiX develops and distributes products containing its proprietary ingredients for topical aesthetic applications. These offerings include ZEO GROW X, a professional-grade formula delivering concentrated topical exosomes to support follicular function, as well as ZEO GROW BOOST and EXO FOLLICLE FUEL. Founded in 2011, the company was formerly known as Organicell Regenerative Medicine, Inc. before rebranding to Zeo ScientifiX, Inc. in February 2024. It is headquartered in Davie, Florida.
Quick stats
Shares outstanding—
Computed float3.0M
Float / sharesUnknown
Cash runway (months)13
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001557376
AI Summary
AI-generated1/11
minorbullishproduct launch
ZEO ScientifiX Launches First-of-Its-Kind ZEO Xperience, a Three-Day Immersive Regenerative Medicine Experience for Healthcare Professionals
ZEO ScientifiX announced the launch of ZEO Xperience, a three-day immersive educational event tailored for healthcare professionals in the regenerative medicine field.
Scheduled for October 23-25 in Fort Lauderdale, the event focuses on biologics education, hands-on clinical training, and practice growth strategies.
CEO Ian Bothwell emphasized that the initiative aims to move beyond traditional lectures to provide practical implementation strategies for clinicians.